Trade

Alpa Laboratories share price

Balanced risk
  • 36%Low risk
  • 36%Moderate risk
  • 36%Balanced risk
  • 36%High risk
  • 36%Extreme risk
  • 63.90(-2.74%)
    January 23, 2026 14:32:13 PM IST
    • NSE
    • BSE
  • Vol : 11.24 K (NSE + BSE)
    Last 20 day avg : 15.63 K

Alpa Laboratories is trading -2.74% lower at Rs 63.90 as compared to its last closing price. Alpa Laboratories has been trading in the price range of 68.13 & 61.72. Alpa Laboratories has given -16.05% in this year & -8.71% in the last 5 days. Alpa Laboratories has TTM P/E ratio 10.01 as compared to the sector P/E of 22.37.The company posted a net profit of 0.11 Crores in its last quarter.Listed peers of Alpa Laboratories include Cipla (-4.53%), Divi's Laboratories (-1.23%), Dr Reddy's Laboratories (1.73%).The Mutual Fund holding in Alpa Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Alpa Laboratories was at 0.36% in 31 Dec 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 23, 2026, 09:21 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.19
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.00
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.62
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
61.72
Highest
68.13
52 week range
Lowest
61.18
Highest
136.90
Alpa Laboratories Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Cipla
Bearish
1,309.45-4.531,05,738.9822.953.870.870.81
Divi's Laboratories
Bearish
5,997.70-1.231,58,997.5478.6111.520.460.01
Dr Reddy's Laboratories
Neutral
1,238.151.731,03,334.9218.633.140.632.34
Sun Pharmaceutical Industries
Bearish
1,633.40-0.063,91,778.2936.245.770.920.50
Torrent Pharmaceuticals
Bullish
3,946.85-1.921,33,696.9067.3217.10.8317.62
Alpa Laboratories Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-14Quarterly Results
2025-08-13Quarterly Results & A.G.M.
2025-05-28Audited Results
2025-02-13Quarterly Results & Others
2024-11-14Quarterly Results
About the company Alpa Laboratories
  • IndustryBiotechnology & Drugs
  • ISININE385I01010
  • BSE Code532878
  • NSE CodeALPA
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
  • Management Info
  • Purushottam PatelChairman of the Board
  • Jayesh PatelChief Executive Officer
  • Bakulesh ShahChief Financial Officer
  • Srashti ChopraCompliance Officer and Company Secretary
  • Paresh ChawlaManaging Director, Director
  • Mahendra ChawlaWhole-Time Director
  • Pravin ShahWhole Time Director
  • Shitul ShahAdditional Director
Alpa Laboratories Share Price FAQs

Alpa Laboratories is trading at 63.90 as on Fri Jan 23 2026 09:02:13. This is -2.74% lower as compared to its previous closing price of 65.70.

The market capitalization of Alpa Laboratories is 136.87 Cr as on Fri Jan 23 2026 09:02:13.

The 52 wk high for Alpa Laboratories is 136.90 whereas the 52 wk low is 61.18

Alpa Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 10.01
  • Sector P/E: 22.37
  • Dividend Yield: 0.00%
  • D/E ratio: 0.00

Alpa Laboratories reported a net profit of 19.50 Cr in 2025.